TEDG - highlights
KEY HIGHLIGHTS ON TEDG
- Human Vaccine Producer - the Company is one of China's largest non-governmental human vaccine producers. Their main focus is vaccines for highly contagious and deadly human diseases.
- H5N1 Bird Flu Research - the Company has received a copy of the H5 virus strain from the NIBSC (National Institute for Biological Standard and Control), and has begun testing in animals.
- Influenza Vaccine - the Company has a working Influenza vaccine already in the market, which can easily be paired with the H5N1 virus for a vaccine.
- Chiron Vaccines - the Company has a number of ex-executives from Chiron Vaccines. The ex-President of Chiron Vaccines is on the Board of Advisors, and the CEO headed Chiron Vaccines China Division.
- WHO and CDC Advisors - the Company also has a few Board of Advisors who have worked for the WHO, and China's CDC.
- Revenues & Profitable - the Company did $9 million in vaccines sales for 2005, and turned a profit of around $1.5 million.
- $1.31 Price Target - Ludlow Capital has a $1.31 price target on TEDG
TEDG - .53 x .55
